| abstract |
The novel naphlyridine compound of Formula 1 whereinnsubstituents are specific. It shows antagonismntachykinmine receptors useful asna proylactic or therapeutic agent for diseases that arencaused by tachykinin receptors. By a specific examplensuch compounds are 2 - [(-) - 4- (N-benzoyl-N-methyl) amino] -3-n(3,4-dichlorophenyl) butyl] -10-acetylamino-1,2,3,4-tetrahydrobenzo [b] [1,6] naphthyridine. |